Loading...

World-Class Retina Care. Community-Based Caring.

Texas Retina Participating in New Phase III Clinical Trial for Uveal Melanoma

Posted On October 13, 2025 / By / Posted in Blog

Texas Retina Participating in New Phase III Clinical Trial for Uveal Melanoma

Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina will soon begin enrolling patients in the OptimUM-10 clinical trial, a randomized, Phase III, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic

read more
Posted On October 8, 2025 / By / Posted in Blog

Eye Injury Prevention Month: Four Tips to Protect Your Eyes

Thousands of eye accidents happen each day, and according to the American Academy of Ophthalmology (AAO), nearly half of all eye injuries occur in the home. Did you know that wearing protective

read more
Posted On September 30, 2025 / By / Posted in Blog

Getting to Know Benjamin R. Lin, MD

Board-certified ophthalmologist and retina specialist Benjamin R. Lin, MD, joined Texas Retina in September and cares for patients in our Dallas Main, Dallas North and Plano offices. He came to us from

read more
Posted On September 5, 2025 / By / Posted in Blog

Welcome Benjamin R. Lin, MD!

Texas Retina is pleased to welcome board-certified ophthalmologist and retina specialist Benjamin R. Lin, MD, to our practice on September 2, 2025. Serving patients in our Dallas Main, Dallas North and Plano

read more
Posted On August 12, 2025 / By / Posted in Blog

Why Your Appointment May Take Longer Than Anticipated

We often have patients and family members ask why they have to wait or why their appointment is taking so long, especially if they see other patients called back before them. We

read more
Posted On August 6, 2025 / By / Posted in Blog

Dr. Abbey Delivered On-Demand Presentation About the PHOTON DME Study for ASRS 2025 Meeting

On behalf of the PHOTON study investigators, Texas Retina’s Ashkan M. Abbey, MD, delivered an on-demand presentation titled “Differential Anatomic Response to Aflibercept 8 mg vs 2 mg During Matched Dosing Phase

read more
Posted On July 28, 2025 / By / Posted in Blog

Dr. Nikisha Kothari Selected as “One to Watch” in Retina Today

Texas Retina’s Dr. Nikisha Kothari has been selected as a “One to Watch” in the July/August issue of Retina Today. This feature highlights individuals identified as future leaders in the field of

read more
Posted On July 8, 2025 / By / Posted in Blog

July is UV Safety Month — Debunking Seven Common Myths About Sunglasses

When most people think of UV protection, they think of their skin and sunscreen. Did you know that long-term exposure to bright sunlight may also increase your risk of eye disease? July

read more
Posted On June 16, 2025 / By / Posted in Blog

Initial Results of Phase Ib LOTUS Clinical Trial on Potential New Diabetic Macular Edema Treatment Released

On June 9, 2025, Eluminex Biosciences Limited, a clinical-stage protein therapeutics company, announced positive topline safety, tolerability, and pharmacodynamic data from the multicenter LOTUS Part 1 clinical trial of EB-105 in patients

read more
Posted On June 13, 2025 / By / Posted in Blog

11 Tips to Protect Men’s Eye Health

June is Men’s Health Month. It was established to help bring awareness to health issues men face and to encourage them to take charge of their health. A number of retinal diseases can affect

read more